PHOTO
- UAE, Saudi Arabia, Egypt, and Kazakhstan were all certified for the first time this year.
Dubai – Takeda Pharmaceutical Company Limited [TSE: 4502 / NYSE: TAK], (“Takeda”) today announced it has become part of a select group to receive global Top Employer. In ICMEA, the Top Employer certification went for the third time running to Takeda entities in Turkey, Ukraine, and South Africa. In addition, UAE, Saudi Arabia, Egypt, and Kazakhstan were all certified for the first time.
Gonzalo Ponce Gutierrez, Head of Human Resources, ICMEA said “With a fast-expanding presence in the region, Takeda is committed to growing as an employer of choice and as a great place to work, driven by a steadfast focus on flexibility, inclusion and employee wellness. To be recognized as a Top Employer in seven countries across ICMEA is a testament to our work which seeks to deliver exceptional people-experiences in every place we operate. It is important that every colleague at Takeda can fulfill their potential while helping to create a brighter future for millions of patients worldwide.”
Takeda surpassed the requirements of the Top Employers Institute, with particular distinction in the areas of Talent Strategy, Career & Succession Management, and Performance Management, receiving accreditation in more than 30 countries, seven of which are in the ICMEA area:
- Middle East:Egypt, Saudi Arabia, and the United Arab Emirates
- CIS Countries: Ukraine and Kazakhstan
- Africa: South Africa
Established over 25 years ago, the award certification is given annually by the Top Employers Institute to companies with an outstanding employee offering. Takeda has surpassed the requirements of the Top Employers Institute, with distinction in the areas of talent strategy, career & succession management and performance management, receiving accreditation in more than 30 countries in the Asia Pacific, North America, Africa, Europe, Latin America, and the Middle East.
-Ends-
The Top Employers Institute assesses 600 “People Development” practices of companies across 10 areas:
- Talent Strategy
- Performance Management
- Workforce Planning
- Leadership Development
- Talent Acquisition
- Career & Succession Management
- On-boarding
- Compensation & Benefits
- Learning & Development
- Culture
To learn more about the Top Employers Institute and the Top Employers certification please visit: www.topemployers.com.
About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries.
For more information, visit https://www.takeda.com.
Media Contacts
Yasmeen Al Shyoukh
Yasmeen.Alshyoukh@fleishmaneurope.com
+971503000938
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
